Budesonide for the Induction and Maintenance of Remission in Crohn’s Disease: Systematic Review and Meta-Analysis for the Cochrane Collaboration

BACKGROUND: Budesonide is an oral glucocorticoid designed for the treatment of inflammatory bowel disease (IBD) that may reduce systemic adverse events (AEs). This review examined the efficacy and safety of budesonide for the induction and maintenance of clinical remission in Crohn’s disease (CD). M...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Can Assoc Gastroenterol
Autors principals: Kuenzig, M Ellen, Rezaie, Ali, Kaplan, Gilaad G, Otley, Anthony R, Steinhart, A Hillary, Griffiths, Anne Marie, Benchimol, Eric I, Seow, Cynthia H
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2018
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6328928/
https://ncbi.nlm.nih.gov/pubmed/30656288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy018
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars